Product
DEB-TACE combined with apatinib and PD-1 antibody
1 clinical trial
4 indications
Indication
CholangiocarcinomaIndication
Transarterial ChemoembolizationIndication
ApatinibIndication
PD-1 inhibitorClinical trial
Drug-eluting Beads Transarterial Chemoembolization Combined With Apatinib and PD-1 Antibody for the Treatment of Intrahepatic Cholangiocarcinoma That Has Progressed After Standard First-line ChemotherapyStatus: Recruiting, Estimated PCD: 2025-04-30